AME — AMETEK, Inc.

Wall Street is bullish after Q2 2026 revenue rose 15% y/y, orders surged 28% y/y for a second straight quarter, adjusted EPS jumped 17%, and full-year guidance was raised. The consensus rating is Buy (20 buy / 10 hold, no sells), with a consensus target near $273 and recent bullish targets up to $316, although some models caution that the stock is rich versus its own history.

Revenue was basically flat through 2024 and early 2025, hovering in the $1.70-$1.78B quarterly range, then inflected sharply higher: Q3 2025 +10.8% y/y, Q4 2025 +13.5% y/y, Q1 2026 +11.3% y/y, and Q2 2026 +15.0% y/y to $2.04B. Diluted EPS climbed from $1.34 in Q1 2024 to $1.77 in Q2 2026, operating margin held near 26%, and Q2 2026 free cash flow was $451.7M versus $329.8M a year earlier. This looks like a genuine acceleration, not a one-quarter blip, especially with two consecutive quarters of 28% order growth.

Expensive versus its own history. Trailing P/E is 35.5x versus the 5-year average of 30.6x, P/S is 7.1x versus 5.9x, and the reported PEG ratio is 3.4. On forward FY2026 consensus EPS of $8.32 the stock is less extreme at roughly 29.3x, but the rich trailing multiple leaves little room for error if growth slows or integration stumbles.

At $243.67, the market is paying roughly 29x forward adjusted EPS, effectively looking through the high trailing multiple by assuming earnings grow from trailing GAAP EPS of $6.88 toward the guided $8.20-$8.30. The playbook is 'pay up for a compounder and hope order momentum plus Indicor synergies keep estimates rising.' If that works, the forward multiple becomes more reasonable; if orders roll over or integration disappoints, both EPS estimates and the multiple can compress together.

As of 2026-08-27, RSI was 48.1, which is neutral. The stock was 2.1% below its 20-day SMA but 0.9% above its 50-day SMA and 8.4% above its 200-day SMA, so the longer-term uptrend is intact but short-term momentum is consolidating after trading near the $261 high. There is no overbought or oversold timing signal; a pullback toward the 50-day near $242 or the 200-day near $225 would offer a more attractive entry.

• AI infrastructure and data-center power management are driving secular demand for AMETEK's instrumentation and precision components.
• Semiconductor capital equipment demand is supportive now, but that cycle is historically volatile and can reverse quickly.
• Elevated but stabilizing interest rates raise the cost of carrying materially more debt after the $5B Indicor deal, though pre-deal leverage was low.
• Aerospace and defense spending remains a tailwind for specialized electronic instruments and aftermarket content.
• Tariff and supply-chain input cost uncertainty is a lingering risk, partially offset by pricing power that has protected roughly 26% operating margins.

• Q3 2026 earnings in late October/early November 2026, the first full report to include Indicor contribution and integration commentary.
• Indicor integration milestones and realization of expected synergies; any further accretive capital deployment.
• Continued order momentum, with Q2 2026 orders up 28% y/y, and the potential for further upward guidance revisions.
• The regular quarterly dividend of $0.34 per share payable on September 30, 2026, signaling continued capital-return confidence.

• Integration and leverage risk from the $5.0B all-cash Indicor acquisition; the balance sheet data is pre-deal and net debt will rise materially.
• Valuation/multiple compression risk: at 35.5x trailing earnings versus a 30.6x 5-year average, any guidance miss could hit the stock hard.
• Cyclical exposure through semiconductor and industrial capital spending; order momentum can reverse if end markets cool.
• Tariff/input cost inflation could pressure margins if pricing power fades, and the 0.56% dividend yield provides very little valuation support.

AMETEK is a high-quality industrial compounder with accelerating revenue, roughly 26% operating margins, strong free cash flow, and a larger aftermarket-heavy platform after Indicor. But as of 2026-08-27 the stock is priced at a premium to its own history and the $5B integration has just begun, so I view it as a good business trading at a full price rather than a compelling new-money entry point.

Calculated by applying AMETEK's 5-year average trailing P/E of roughly 30.6x to forward consensus EPS of $8.32, yielding approximately $255; this credits the company's high-quality accelerating fundamentals while not paying a further premium for unproven Indicor integration.